[go: up one dir, main page]

NO971376L - N-substituerte piperidinyl bisykliske benzoatderivater - Google Patents

N-substituerte piperidinyl bisykliske benzoatderivater

Info

Publication number
NO971376L
NO971376L NO971376A NO971376A NO971376L NO 971376 L NO971376 L NO 971376L NO 971376 A NO971376 A NO 971376A NO 971376 A NO971376 A NO 971376A NO 971376 L NO971376 L NO 971376L
Authority
NO
Norway
Prior art keywords
6alkyl
substituted
halo
hydrogen
alk
Prior art date
Application number
NO971376A
Other languages
English (en)
Other versions
NO971376D0 (no
NO313238B1 (no
Inventor
Georges Henri Paul Van Daele
Jean-Paul Rene Marie A Bosmans
Frans Maria Alfons Van Keybus
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of NO971376D0 publication Critical patent/NO971376D0/no
Publication of NO971376L publication Critical patent/NO971376L/no
Publication of NO313238B1 publication Critical patent/NO313238B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10Laxatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO19971376A 1994-09-27 1997-03-24 N-substituerte piperidinyl bisykliske benzoatderivater NO313238B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP94202792 1994-09-27
US45548695A 1995-05-31 1995-05-31
PCT/EP1995/003691 WO1996010027A1 (en) 1994-09-27 1995-09-19 N-substituted piperidinyl bicyclic benzoate derivatives

Publications (3)

Publication Number Publication Date
NO971376D0 NO971376D0 (no) 1997-03-24
NO971376L true NO971376L (no) 1997-05-05
NO313238B1 NO313238B1 (no) 2002-09-02

Family

ID=26136613

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19971376A NO313238B1 (no) 1994-09-27 1997-03-24 N-substituerte piperidinyl bisykliske benzoatderivater

Country Status (23)

Country Link
EP (1) EP0784620B1 (no)
JP (1) JP3953097B2 (no)
CN (1) CN1068880C (no)
AT (1) ATE187453T1 (no)
AU (1) AU699152B2 (no)
BR (1) BR9509036A (no)
CA (1) CA2200578C (no)
CZ (1) CZ289031B6 (no)
DE (1) DE69513846T2 (no)
DK (1) DK0784620T3 (no)
ES (1) ES2141383T3 (no)
FI (1) FI119640B (no)
GR (1) GR3032646T3 (no)
HU (1) HU218698B (no)
IL (1) IL115413A (no)
MY (1) MY113202A (no)
NO (1) NO313238B1 (no)
NZ (1) NZ293605A (no)
PL (1) PL182502B1 (no)
PT (1) PT784620E (no)
RU (1) RU2154064C2 (no)
WO (1) WO1996010027A1 (no)
ZA (1) ZA958081B (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002514643A (ja) * 1998-05-14 2002-05-21 エギシュ ヂョヂセルヂャール エルテー ベンゾフラン誘導体、それを含有する製薬学的な組成物及びその活性成分の製造方法。
PL214274B1 (pl) * 2002-01-16 2013-07-31 Movetis N V N-Tlenek prukaloprydu, sposób jego wytwarzania i zastosowanie oraz zawierająca go kompozycja i sposób jej wytwarzania
WO2005061483A2 (en) * 2003-12-23 2005-07-07 Bio-Medisinsk Innovasjon As Modulators of peripheral 5-ht receptors
NZ551603A (en) 2004-06-24 2010-11-26 Incyte Corp N-substituted piperidines and their use as pharmaceuticals
KR101561482B1 (ko) 2005-11-08 2015-10-20 버텍스 파마슈티칼스 인코포레이티드 Atp 결합 카세트 수송체의 헤테로사이클릭 조정제
NZ581259A (en) 2007-05-09 2012-07-27 Vertex Pharma Modulators of cystic fibrosis transmembrane conductance regulator
NZ585794A (en) 2007-12-07 2012-05-25 Vertex Pharma Processes for producing cycloalkylcarboxamido-pyridine benzoic acids
HUE031913T2 (en) 2007-12-07 2017-08-28 Vertex Pharma Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid
ES2647531T3 (es) 2008-02-28 2017-12-22 Vertex Pharmaceuticals Incorporated Derivados de heteroarilo como moduladores de CFTR
ME02446B (me) * 2010-04-07 2016-09-20 Vertex Pharma Čvrste forme 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioksol-5-il)ciklopropankarboksiamido)-3-metilpiridin-2-il)benzoeve kiseline
LT3150198T (lt) 2010-04-07 2021-12-10 Vertex Pharmaceuticals Incorporated 3-(6-(1-(2,2-difluorbenzo[d][1,3]dioksol-5-il) ciklopropankarboksamido)-3-metilpiridin-2-il)benzoinės rūgšties farmacinė kompozicija ir jos įvedimas
CN108066306B (zh) 2012-01-25 2021-09-07 沃泰克斯药物股份有限公司 药物制剂及其制备方法
NZ720958A (en) 2013-11-12 2022-02-25 Vertex Pharma Process of preparing pharmaceutical compositions for the treatment of cftr mediated diseases
PT3221692T (pt) 2014-11-18 2021-09-10 Vertex Pharma Processo de realização de testagem de alta produtividade por cromatografia líquida de alta eficiência

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1593569A3 (ru) * 1982-07-30 1990-09-15 Janssen Pharmaceutica Nv Cпocoб пoлучehия пpoизboдhыx n-(3-гидpokcи-4-пипepидиhил)бehзamидa или иx kиcлotho-aддиtиbhыx coлeй
CA1317940C (en) * 1987-09-25 1993-05-18 Georges H. P. Van Daele Substituted n-(1-alkyl-3-hydroxy-4-piperidinyl)benzamides
DE3810552A1 (de) * 1988-03-29 1989-10-19 Sandoz Ag Ester und amide von indol-, benzo(b)thiopen-, benzo(b)furancarbonsaeuren oder 4-amino-2-methoxy-benzolsaeuren mit n-heterocyclischen oder n-heterobicyclischen alkoholen oder aminen, verfahren zu deren herstellung sie enthaltende pharmazeutische zusammensetzungen sowie applikator zur verabreichung derselben
US5374637A (en) * 1989-03-22 1994-12-20 Janssen Pharmaceutica N.V. N-(3-hydroxy-4-piperidinyl)(dihydrobenzofuran, dihydro-2H-benzopyran or dihydrobenzodioxin)carboxamide derivatives
GB9005014D0 (en) * 1990-03-06 1990-05-02 Janssen Pharmaceutica Nv N.(4.piperidinyl)(dihydrobenzofuran or dihydro.2h.benzopyran)carboxamide derivatives
EP0600955A1 (en) * 1991-08-20 1994-06-15 Smithkline Beecham Plc 5-ht4 receptor antagonists
MX9306311A (es) * 1992-10-13 1994-04-29 Smithkline Beecham Plc Compuestos antagonistas del receptor de 5-ht4, procedimiento para su preparacion y composiciones farmaceuticas que los contienen

Also Published As

Publication number Publication date
FI119640B (fi) 2009-01-30
ATE187453T1 (de) 1999-12-15
CN1166171A (zh) 1997-11-26
CN1068880C (zh) 2001-07-25
FI971274A0 (fi) 1997-03-26
PL319997A1 (en) 1997-09-01
RU2154064C2 (ru) 2000-08-10
CA2200578C (en) 2006-11-07
PT784620E (pt) 2000-05-31
JP3953097B2 (ja) 2007-08-01
WO1996010027A1 (en) 1996-04-04
EP0784620B1 (en) 1999-12-08
CZ91897A3 (en) 1997-12-17
ZA958081B (en) 1997-03-26
NO971376D0 (no) 1997-03-24
DE69513846T2 (de) 2000-07-06
GR3032646T3 (en) 2000-06-30
BR9509036A (pt) 1997-10-14
NO313238B1 (no) 2002-09-02
HUT77173A (hu) 1998-03-02
CZ289031B6 (cs) 2001-10-17
HU218698B (hu) 2000-11-28
IL115413A0 (en) 1995-12-31
ES2141383T3 (es) 2000-03-16
IL115413A (en) 2000-02-17
DE69513846D1 (de) 2000-01-13
PL182502B1 (pl) 2002-01-31
DK0784620T3 (da) 2000-05-22
CA2200578A1 (en) 1996-04-04
FI971274A7 (fi) 1997-03-26
AU699152B2 (en) 1998-11-26
NZ293605A (en) 1998-07-28
MY113202A (en) 2001-12-31
JPH10506118A (ja) 1998-06-16
AU3608195A (en) 1996-04-19
MX9702363A (es) 1997-10-31
EP0784620A1 (en) 1997-07-23

Similar Documents

Publication Publication Date Title
NO971376L (no) N-substituerte piperidinyl bisykliske benzoatderivater
ES449191A1 (es) Un procedimiento de preparacion de derivados de 4,5,6,7-te- trahidro-tieno-(2,3-c)-piridina.
TW369526B (en) Diazabicyclic neurokinin antagonists
DE60040901D1 (de) Polyhydroxyalkanoat
BG93979A (bg) Производни на n-(4-пиперидинил)(дихидробензофуран или дихидро-2н-бензопиран)карбоксамид, фармацевтичен състав, който ги съдържа, метод за получаване на производните и приложението им
DK0447285T3 (da) Nephtalenderivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler indeholdende dem
MY101359A (en) 7-acylamino-3-vinylcephalosporanic acid derivatives, processes for their preparation, pharmaceutical compositions containing them, their starting compounds and their preparation
DE60139639D1 (de) Substituierte thiazolderivate mit 3-pyridylgruppen, verfahren zu deren herstellung und deren verwendung
DE69122941D1 (de) Piperazinderivate
MY120248A (en) Water soluble azoles as broad-spectrum antifungals
NO930143D0 (no) Piperidinforbindelser, deres fremstilling og bruk
PL322872A1 (en) Novel triazolones - inhibitors of b apolipoprotein synthesis
TW360653B (en) A oxadiazole compound having colon motility stimulating properties, its preparation process and its pharmaceutical composition
ATE212996T1 (de) Anthracyclin-derivate
DK1150974T3 (da) Heterocykliske derivater som inhibitor af faktor Xa
AP1396A (en) 1-Trifluoromethyl-4-hydroxy-7-piperidinylaminomethylchroman derivatives.
HUP9900895A2 (hu) Simaizom sejtburjánzást gátló 2-szubsztituált benzimidazolszármazékok
JO1648B1 (en) Nitrogen compounds
JO1697B1 (en) Pyridine derivatives

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees